Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Neoplasms, Plasma Cell × belinostat × 1 year × Clear all

Sponsor

Conditions

Lymphoma, T-Cell, Peripheral 3 Myelodysplastic Syndromes 2 Lymphoma, T-Cell, Cutaneous 2 Lymphoma, T-Cell 2 Lymphoma, Non-Hodgkin 2 Leukemia, Myeloid, Acute 2 Breast Neoplasms 2 Uveal Melanoma 1 Ovarian Neoplasms 1 Neuroendocrine Tumors 1 Mycosis Fungoides 1 Lymphoma, Large-Cell, Anaplastic 1 Lymphoma, Follicular 1 Lymphoma, B-Cell, Marginal Zone 1 Lymphoma, B-Cell 1 Leukemia-Lymphoma, Adult T-Cell 1 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1 Immunoblastic Lymphadenopathy 1 Hodgkin Disease 1 Hematologic Neoplasms 1 Eye Neoplasms 1 Carcinoma, Transitional Cell 1 Carcinoma, Neuroendocrine 1 Blast Crisis 1

Interventions

Dexamethasone 16 Lenalidomide 12 Bortezomib 9 Cyclophosphamide 7 carfilzomib 6 Whole-Body Irradiation 6 Melphalan 6 fludarabine 5 daratumumab 5 Tacrolimus 5 Mycophenolic Acid 5 Calcium Dobesilate 5 pomalidomide 3 fludarabine phosphate 3 belantamab mafodotin 3 Radiotherapy 3 gamma-Globulins 2 elotuzumab 2 Trimethoprim, Sulfamethoxazole Drug Combination 2 Sirolimus 2 Prednisone 2 Immunoglobulins, Intravenous 2 Hematopoietic Stem Cell Transplantation 2 Etoposide 2 venetoclax 1 thymoglobulin 1 siltuximab 1 poly ICLC 1 pembrolizumab 1 ixazomib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡